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Abstract. Acute Coronary Syndrome (ACS) is a series of clinical disorders caused by acute 
ischemic heart disease. The clinical spectrum of ACS is unstable angina pectoris (UAP), non  
ST segment elevation myocardial infarction (NSTEMI) and ST segment elevation 
myocardial infarction (STEMI). Inflammation occurs from the early stages of atheroma 
formation to plaque rupture and thrombosis. Thrombocytosis and lymphopenia are associated 
with the degree of systemic inflammation and the platelet lymphocyte ratio (PLR) is a new 
marker involving both hematological indices. ST segment elevation myocardial infarction is 
a type of acute myocardial infarction with high mortality. Management of STEMI patients is 
carried out with reperfusion therapy consisting of primary percutaneous coronary 
intervention (PCI) and fibrinolytics. Contrast-induced nephropathy is a serious complication 
of angiograph procedures that results from administration of contrast media. 
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1. Introduction 
Acute myocardial infarction (AMI) is one of the most cardiovascular diseases in hospitalized 
patients in industrialized countries [1]. According to WHO, myocardial infarction is classified 
based on symptoms, ECG image abnormalities, and heart enzymes. Myocardial infarction can be 
divided into non ST segment elevation myocardial infarction (NSTEMI), and ST segment 
elevation myocardial infarction (STEMI) [2]. STEMI is a condition that results in cardiac 
myocyte cell death due to prolonged ischemia due to acute coronary occlusion [3]. Coronary 
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occlusion occurs due to atherosclerosis, a disease caused by an inflammatory process that involves 
the interaction of immune mechanisms and several metabolic substances accompanied by 
accumulation of lipids on the artery walls. 
Lymphocytopenia is a condition that is often found in chronic inflammatory conditions due to 
increased lymphocyte apoptosis. Lymphocyte value can be used as an early sign of physiological 
stress and systemic inflammation. The increase in the number of megakaryocytes and 
thrombocytosis are two results due to the inflammatory state, which can lead to a prothrombotic 
state. Circulating platelets contribute to atheroma plaque formation and triggering further 
complications. Platelet Lymphocyte Ratio (PLR) is a novel prognostic marker and a marker of 
systemic inflammation that describes the aggregation and inflammation pathways in coronary 
heart disease. 
The initial management of STEMI is reperfusion therapy, either with percutaneous coronary 
intervention (PCI) or pharmacology [4]. Primary PCI is an action to drain coronary arteries that 
are blocked by thrombus, which causes STEMI by using coronary catheters whether followed by 
stenting or not. One of the complications of the PCI procedure is the incidence of contrast-induced 
nephropathy. Contrast-induced nephropathy (CIN) is an acute impairment of renal function, 
assessed by an increase in serum creatinine of more than 25% or 0.5 mg / dL within 48–72 hours 
after intravenous contrast administration [5]. 
In previous studies, PLR value have been known to be correlated with CIN. PLR value was found 
higher in CIN group compared to non CIN group. PLR value is an independent predictor of the 
incidence of CIN in STEMI patients undergoing primary PCI. Age, Killip Class and NLR values 
were other independent predictors of the incidence of CIN [6]. 
The high PLR value may be the result of the inflammatory process CIN. The advantage of PLR 
values is that the platelet and lymphocyte components reflect coagulation and inflammatory 
activity, both of which are important mechanisms for inducing contrast-induced nephropathy. 
PLR values can help identify high-risk candidate patients for CIN [7]. 
This study was conducted to determine the correlation in the use of PLR values with the incidence 
of contrast-induced nephropathy in STEMI patients undergoing primary PCI in North Sumatra. 
The results of this study are expected to provide education and prognosis to patients. 
2. Materials and Methods 
2.1. Place and Year Work 
The present study was carried out from June – December 2020. The experiment was conducted 
in cardiac centre of H. Adam Malik General Hospital. 
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2.2. Ethics Statement 
The research was approved by The Health Research Ethical Committee of Faculty of Medicine, 
Universitas Sumatera Utara. Written informed consent was obtained prior to the investigation. 
2.3. Subjects 
The study included a total of 61 STEMI patients undergoing primary PCI. Each individual was 
recruited from the  H. Adam Malik General hospital, Murni Teguh Memorial hospital and Grand 
Medistra hospital, North Sumatra, Indonesia from January 2019 to November 2019. Inclusion 
criteria include STEMI patients undergoing primary PCI;serum creatinine test is carried out at 
admission and 48 hours after the primary PCI. 
2.4. Statistical Analysis 
For baseline characteristics, the Kolmogorov-Smirnov test was used to test the normality of 
distribution. Quantitative variables with a normal distribution were specified as mean (standard 
deviation), variables with nonnormal distribution were shown as median (interquartile range), and 
categorical variables were shown as number and percentage values. For continuous variables with 
a normal distribution, the Student t test was used to compare groups, whereas the Mann-Whitney 
U test was used when the distribution was not normal. For categorical variables, the 𝑥2 test or the 
Fisher exact test was used, as appropriate. All statistical analysis was performed using Statistical 
Package for Social Sciences (SPSS) version 26. P < 0.05 were considered significant. 
3. Results 
The study population consisted of 61 patients; 11 (18%) patients developed CIN and 50 (82%) 
patients with non-CIN. Baseline demographic data and laboratory parameters are shown in Table 
1. The patients in the CIN group had a higher prevalence of hypertension and diabetes mellitus 
than those in the non-CIN group. In the CIN group, creatinine, ureum, HDL, triglyserides, white 
blood cell, neutrophil, platelet, and PLR were higher, whereas CrCL, LDL, hematocrit, 
lymphocyte, and hemoglobin were lower compared with the non-CIN group. 
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Table 1 Baseline Demographic Data and Laboratory Parameters. 
Variable Contrast-Induced Nephropathy p value 
 CIN (+) (n=11,18%) CIN(-) (n=50,82%) 
Demographic data    
Age ( years) 54.64±7.42 56.50±9.15 0.531 
Sex (n,%) 
Male 8 (72.7) 46 (92.0) 0.103 
Female 3 (27.3) 4 (8.0) 0.103 
Hypertension (n,%) 7 (63.6) 25 (50.0) 0.412 
Diabetic Melitus (n,%) 4 (36.4) 6 (12.0) 0.07 
Smoking (n,%) 8 (72.7) 44 (88.0) 0.343 
Congestive Heart Failure (n,%) 5 (45.5) 9 (18.0) 0.106 
Anemia (n,%) 4 (36.4) 8 (16.0) 0.203 
Laboratorium parameters 
Creatinine pre PCI (mg/dL) 1.089±0.1 1.07±0.29 0.880 
Cretinine post PCI (mg/dL) 1.4±0.14 0.99±0.27 <0.001 
Ureum pre PCI (mg/dL) 24 (15-37.5) 28.2 (15-56) 0.208 
Ureum post PCI (mg/dL) 43 (34-47) 26 (15-55) <0.001 
CrCL pre PCI (mg/dL) 73.86 (42.08-116.34) 75.66 (36.83-326.39) 0.499 
CrCL post PCI (mg/dL) 58.04 (32.87-91.28) 83.84 (37.49-273.75) 0.001 
Hemoglobin (g/dL) 13.79±2.23 13.96±1.63 0.765 
Hematocrit (%) 40.17±5.94 42.26±5.10 0.237 
Leucocytes (/µL) 13560 (5410-21000) 13105 (7310-22830) 0.505 
Platelet (x103/µL) 284.27±69.96 275.32±78.13 0.728 
Neutrophils (x103/µL) 13.93 (3.70-89.40) 10.93 (4.90-89.40) 0.042 
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Lymphocytes (x103/µL) 1.5 (0.73-2.44) 1.88 (0.74-10.20) 0.013 
Monocytes (x103/µL) 0.88 (0.30-11.50) 0.59 (0.25-7.70) 0.91 
Eosinophils (x103/µL) 0.02 (0.00-0.15) 0.07 (0.00-0.64) 0.061 
Basophils (x103/µL) 0.04 (0.01-0.10) 0.05 (0.01-0.2) 0.449 
PLR 216.38±69.46 146.29±61.62 0.001 
HDL (mg/dL) 44 (30-55) 37.5 (26-55) 0.027 
LDL (mg/dL) 116 (77-224) 122 (56-227) 0.858 
Triglyserides (mg/dL) 122 (35-348) 119 (58-348) 0.750 
 
 
The angiographic characteristics and medications during hospitalization are presented in Table 2. 
The prevalence of multivessel disease was significantly lower in the CIN group compared with 
the non-CIN group. The total used of contrast volume was not significantly different between 
groups. Both group dominated with administration of high osmolality contrast rather than low 
osmolality contrast. The rates of treatment with angiotensin-converting enzyme 
inhibitor/angiotensin receptor blocker and statin were higher in patients who developed CIN. 
 
Table 2 The Angiographic Characteristics and Medications During Hospitalization 
 Contrast-Induced Nephropathy  p-value 
 CIN(+)(n=11,18%) CIN (-) (n=50,82%)  
Angiographic characteristics 
Contrast volume (ml) 100 (80-300) 100 (75-150) 0.229 
Contrast osmolality (n,%)  
High 11 (100) 42 (84) 
8 (16) 
0.330 
Low 0 (0) 
Multi vessel disease (n,%) 3 (27.3) 29 (58) 0.13 
Medications during hospitalization (n,%)   
ACE-inhibitor 7 (63.6) 27 (54) 0.740 
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β-Blocker 5 (45.5) 28 (56) 0.525 
Diuretic 4 (36.4) 21 (42) 0.503 
MRA 2 (18.2) 6 (12) 0.627 
Statin 11 (100) 49 (98) >0.999 
 
An ROC curve analysis was performed to determine the cutoff value of PLR to predict the 
development of CIN. The area under the curve (AUC) for PLR was 0.795 (95% CI) and a PLR 
cutoff of 184.75 or higher predicted CIN with a sensitivity of 81.8% and a specificity of 80% 
(Figure 1) 
Figure 1. The ROC curve shows the predictive cutoff value of PLR for CIN 












F % F % F % 
Cut-off point 
≤184,75 2 (3,3) 40 (65,6) 42 (68,9) 
<0.001 >184,75 9 (14,8) 10 (16,4) 19 (31,1) 
Total 11 (18) 50 (82) 61 (100) 




Contrast-induced nephropathy represents a significant adverse event of contrast medium 
administration, leading to worse clinical outcomes despite successful early coronary 
revascularization. The mechanisms of CIN remain poorly understood, although several 
mechanisms have been identified, revealing a complex multifactorial physiopathology with a high 
interindividual variability of the nephrotoxic effect of contrast media. Several factors have been 
strongly implicated to have some roles in its development of CIN, including intrarenal 
vasoconstriction, reduced renal blood flow, oxidative stress, inflammation, renal ischemia, 
reactive oxygen species formation, reduction of nitric oxide production, tubular epithelial, and 
vascular endothelial injury [8]. 
A recent study showed that a higher PLR value is related to the presence of coronary artery disease 
and is correlated with CRP and fibrinogen levels. Both thrombocytosis and lymphocytopenia 
correlate with the degree of systemic inflammation, and PLR represents a novel marker 
incorporating both hematologic indices. The advantage of the PLR could be that it reflects the 
condition of both inflammation and thrombosis pathways, and it may be more valuable than either 
platelet or lymphocyte counts alone. Since a complete blood count is easily available, the PLR 
may help clinicians to identify patients at high risk of CIN and decide whether postprocedural 
hydration is needed [7]. 
Our analysis showed that , PLR of the CIN group was significantly higher compared to the non-
CIN group, ( 216.38 ± 69.46 vs 146.29 ± 61.62 respectively, p= 0.001) and higher PLR was an 
independent risk factor for the development of CIN in patients with STEMI undergoing pPCI. 
This is in accordance with the research of Sun et al. which found PLR value in CIN group was 
higher compared to non-CIN group ( 173.8 ± 62. vs 116.2 ± 51.7 respectively, p=0.001) The cut 
off of PLR for CIN was 184.75 with a sensitivity of 81.8% and a specificity of 80%, with an AUC 
value of 0.795 (95% CI).Based on demircelik et al study, the cut off of PLR for CIN was 148.3 
with a sensitivity of 75.6% and a specificity of 72.2%, with an AUC value of 0.715 (95% CI) [9]. 
This study has some limitations. The number of study samples is small so the study is could not 
assess other confounding factors. This study examines laboratory parameters in 3 different centers 
and using different devices, even though using the same parameter unit. Several novel renal 
biomarkers, including neutrophil gelatinase-associated lipocalin, cystatin C, urinary Kim-1, and 
interleukin 18, were not measured. 
5. Conclusion 
There is a significant correlation between PLR value and the incidence of CIN in STEMI patients 
undergoing primary PCI. 
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